Company: FTII
Filing Date: 2025-04-09
Form Type: 10-K
Source: 0001641172-25-003384
Chunk: 1049

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-04-09
Form: 10-K
Item: Item 4
Chunk 1049
---
 Hearing will be December 17, 2024. The
letter also contained hearing instructions. On November 27, 2024, the Company timely submitted written materials setting forth grounds
for additional time to regain compliance or alternatively grant the Company’s application to transfer its shares to list on the
Nasdaq Capital Market. On November 27, 2024, the Company submitted an application to transfer from the Nasdaq Global Market to the Nasdaq
Capital Market. On December 11, 2024, the Company received an approval letter from Nasdaq, informing that the Company’s transfer
application has been approved and the Company’s securities will be transferred to the Nasdaq Capital Market at the opening of business
on December 13, 2024.

In
order to regain compliance with Nasdaq, the Company held the Third Extension Meeting on November 18, 2024 at which the stockholders approved
the Founder Share Amendment, and all holders of shares of Class B Common Stock promptly elected to convert all 2,875,000 shares of Class
B Common Stock to 2,875,000 shares of Class A Common Stock. As a result, as of December 3, 2024, the Company has approximately 5,305,595
shares of issued and outstanding listed securities.

As
disclosed in a Form 12b-25 Notification of Late Filing filed with the SEC on November 15, 2024, the Company is delayed in filing its
Quarterly Report on Form 10-Q for the quarter ended December 31, 2024 (the “2024 Q3 10-Q”) with the SEC. Consequently, the
Company received an expected deficiency notification letter from the Staff of Nasdaq dated November 27, 2024 (the “Third Notice”).
The Third Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Rule”)
as a result of its failure to timely file the 2024 Q3 10-Q. The Staff also noted that this serves as an additional basis for delisting
the Company’s securities from Nasdaq and since the Company is already scheduled to appear before a Hearings Panel for its failure
to comply with the Nasdaq Listing Rule 5420(a)(2), the Company has until December 4, 2024 to request a stay of suspension, pending a
Hearings Panel decision. In addition, the Staff noted that